Skip to main content

U of Iowa Licenses DNAStar Software

NEW YORK (GenomeWeb News) – Researchers at The University of Iowa will use DNAStar's Lasergene sequence analysis software under a new four-year site license agreement, the Madison, Wis.-based company said today.

All of the researchers at the school's Iowa City campus will have access to the Lasergene v8.1 software, which may be used in analysis of next-generation sequence data, gene discovery and analysis, simultaneous examination of SNPs from multiple samples, and other features.

The software supports analytical operations on data from Sanger sequencing as well as next-generation platforms from Roche 454, Illumina, Life Technologies' ABI SOLiD, and Helicos, and it can be used in protein analysis applications.

The site license agreement also covers upgrades to the Lasergene software that are released during the contract period.

DNAStar's Director of Marketing, Bob Steinhauser, said in a statement that the site license "brings together many different research groups" and "provides uniformity and standardization" for the school's sequencing software.

Financial terms of the agreement were not released.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.